DTL
AMLX icon

Dynamic Technology Lab’s Amylyx Pharmaceuticals AMLX Stock Holding History

Dynamic Technology Lab’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-31,342
Closed -$461K – 1028
2023
Q4 		$461K Sell
31,342
-6,152
-16% -$94.3K 0.05% 626
2023
Q3 		$687K Buy
+37,494
New +$793K 0.07% 381
2023
Q2 		– Sell
-30,857
Closed -$906K – 972
2023
Q1 		$906K Buy
+30,857
New +$1.07M 0.08% 409

Other funds holding AMLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dynamic Technology Lab's AMLX Position: Q1 2024 in Review

Dynamic Technology Lab sold out of Amylyx Pharmaceuticals (AMLX) in Q1 2024, closing a stake of 31,342 shares — an estimated $461K sold.

Dynamic Technology Lab first reported a position in AMLX in Q1 2023 and held it in 3 quarters. The position peaked at $906K in Q1 2023. 143 funds tracked by Wall St. Rank hold AMLX as of Q1 2024.

  • Dynamic Technology Lab reported no remaining Amylyx Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 31,342 Amylyx Pharmaceuticals shares in Q1 2024, an estimated $461K.
  • Dynamic Technology Lab first reported a position in Amylyx Pharmaceuticals in Q1 2023 and held it in 3 quarters.
  • Dynamic Technology Lab's Amylyx Pharmaceuticals position peaked at $906K in Q1 2023.
  • 143 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2024.

Based on Dynamic Technology Lab's 13F filing for Q1 2024, filed 14 May 2024.